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OBJECTIVE: Moya-moya disease (MMD) is an occlusive cerebral vasculopathy associated with 
high risk of recurrent ischemic and hemorrhagic events. Surgical revascularization had proven 
benefits in ischemic MMD but the role in hemorrhagic presentations is less clear. We studied the 
natural history of symptomatic MMD patients in Hong Kong and compared the long term 
outcome of revascularized patients with those treated conservatively. 
 
METHODS: Patients with MMD managed in three high volume neurosurgical centers from 1997-
2015 in Hong Kong were identified from the Hospital Authority’s clinical data analysis and 
reporting system. The demographic and clinical characteristics, surgical outcome, and follow-up 
information were retrospectively reviewed. The primary outcome was recurrent hemorrhagic and 
ischemic stroke. The annual stroke risk and functional status of patients treated surgically and 
conservatively was compared. 
 
RESULTS: Our cohort included 101 patients with a mean follow-up of 80.2 months. Female-to-
male ratio was 1.8:1. 85.1% of patients had bilateral disease. The mean age of symptom onset 
was 42.6 years, with a bimodal distribution. 54.5% presented with intracranial hemorrhage and 39% 
with cerebral ischemic symptoms. 64 patients were treated conservatively, 15 underwent direct 
vascular bypass and 22 had indirect revascularization. 20 of the 64 (31.3%) patients treated 
conservatively had rebleeding, compared with 5 of 32 (15.6%) of surgically revascularized 
patients. The overall annual stroke risk per patient was significantly lower in revascularized than 
conservatively managed patients (4.6%/year vs 8.3%/year (p=.015). 2 (5.4%) patients in the 
surgical group and 12 (18.8%) in the conservative group died of MMD during the follow up 
period. Surgically treated patients were more likely to have good functional outcome (mRS 0-2) 
at last follow up. (86.1% vs 62.5%, p=.024) 
 
CONCLUSION: Our results confirmed the devastating natural history with high recurrent stroke 
risk in amongst Hong Kong MMD patients treated conservatively. Surgical revascularization 
conferred significant risk reduction for recurrent adverse neurological events, in particular that of 
hemorrhagic stroke. This translated to favourable survival and functional outcome compared with 
conservatively managed patients 
